Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 3—March 2018
Research

Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India

Poonam Ramesh NaikComments to Author , Patrick K. Moonan, Abhay Subhashrao Nirgude, Hemant Deepak Shewade, Srinath Satyanarayana, Pracheth Raghuveer, Malik Parmar, Chinnappareddy Ravichandra, and Anil Singarajipura
Author affiliations: Yenepoya Medical College, Yenepoya University, Mangalore, India (P.R. Naik, A.S. Nirgude, P. Raghuveer); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (P.K. Moonan); International Union Against Tuberculosis and Lung Disease, New Delhi, India (H.D. Shewade, S. Satyanarayana); World Health Organization Country Office for India, New Delhi (M. Parmar); National Tuberculosis Institute, Bangalore, India (C. Ravichandra); Department of Health and Family Welfare, Government of Karnataka, Bangalore (A. Singarajipura)

Main Article

Figure

Locations of the 3 drug-resistant TB treatment centers in the state of Karnataka, India.

Figure. Locations of the 3 drug-resistant TB treatment centers in the state of Karnataka, India. Inset shows location of Karnataka in India.

Main Article

Page created: February 15, 2018
Page updated: February 15, 2018
Page reviewed: February 15, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external